SCHEMBL8479733

SCHEMBL8479733

CC(=O)N(Nc1ccccc1)c1ccccc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALOX15 P16050 1/20 0.42
▸ FABP4 P15090 1/20 0.41
▸ PTPN1 P18031 2/20 0.40
▸ NAPRT Q6XQN6 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ CA12 O43570 2/20 0.40
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ CA4 P22748 2/20 0.40
▸ CA7 P43166 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8485493 0.91 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL8479485 0.90 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL8606406 0.88 LMNA (0.48) ALDH1A1HPGDGAARAB9ASMN1; SMN2
SCHEMBL8855171 0.87 HTT (0.45) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL9094581 0.82 GRIK1 (0.48) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL9094525 0.82 KDM4E (0.46) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL9093965 0.82 KEAP1 (0.41) ALDH1A1HPGDGAARAB9ASMN1; SMN2
SCHEMBL8608850 0.80 KDM4E (0.43) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL9094620 0.77 PBRM1 (0.41) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL8483746 0.77 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925647-A TREATMENT OF INSULIN NON-INSULIN DEPENDENT DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5681958-A TREATMENT OF DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1997-10-28 — — US disclosed
WO-1996010015-A1 CRYPTOLEPINE ANALOGS WITH HYPOGLYCEMIC ACTIVITY SHAMAN PHARMACEUTICALS, INC. (US) 1996-04-04 — — WO disclosed
Send feedback